{"company":{"id":2556042,"name":"Thryv Therapeutics Inc.","domain":"thryvtrx.com","url":"https://alion.io/company/thryvtrx"},"section":"news","answer":"Thryv Therapeutics Inc.: 13 headlines on record, 6 headlines in the last 90 days. Its story counts 5 milestones.","figures":[{"label":"Headlines","value":"13"},{"label":"In 90 days","value":"6"},{"label":"Milestones","value":"5"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":2},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":5}],"news":[{"date":"2026-11-03","kind":"News","title":"Thryv Therapeutics Announces $30 Million Financing to Launch the ASPIRE-HF Study in Patients with Heart Failure; Wave II Efficacy Cohort Fully Enrolled in Long QT Syndrome","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/thryv-therapeutics-announces-30-million-130000270.html"},{"kind":"News","title":"ESC - Online Congress Platform","source":"esc365.escardio.org","url":"https://esc365.escardio.org/esc-congress/sessions/15587-sglt2-inhibitors-in-heart-failure-prevention-and-treatment"}],"story":[{"title":"Raised a round Venture round $30M · YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/thryv-therapeutics-announces-30-million-130000270.html"},{"title":"Certified Thryv Therapeutics announces FDA clearance for Phase 1 Study of THRV-1257 in Anaplastic Thyroid Cancer and acceptance of Late-Breaking Poster Present… · krqe.com","url":"https://krqe.com/business/press-releases/cision/20230815MO83830/thryv-therapeutics-announces-fda-clearance-for-phase-1-study-of-thrv-1257-in-anaplastic-thyroid-cancer-and-acceptance-of-late-breaking-poster-presentation-at-american-thyroid-association-meeting/"},{"title":"Board appointment Thryv Therapeutics Inc. announces the appointment of Pharmaceutical Commercialization Expert Melissa Koomey, M.B.A., to its Board of Directors · Nasdaq","url":"https://nasdaq.com/press-release/thryv-therapeutics-inc.-announces-the-appointment-of-pharmaceutical-commercialization"},{"title":"Website went live first capture in the Wayback Machine","url":"https://web.archive.org/web/20221007180720/thryvtrx.com"},{"title":"Incorporated Thryv Therapeutics Inc."}],"as_of":"2026-11-20","cite":"Thryv Therapeutics Inc., News. Alion, Nov 20, 2026. https://alion.io/company/thryvtrx/news","html_url":"https://alion.io/company/thryvtrx/news","json_url":"https://alion.io/company/thryvtrx/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-20T20:24:03Z"}}